Abstract
Catching the mutants: Pyrimido[4,5-d]pyrimidin-4(1H)-one derivatives (see example) were identified as specific inhibitors of EGFRT790M mutants. The compounds bound with T790M or L858R/T790M mutants with significantly lower Kd values than that with EGFRWT. They also selectively inhibited EGFR signal transduction and proliferation of NSCLC cells harboring EGFRL858R/T790M mutation, but were significantly less potent to cells with EGFRWT.
| Original language | English |
|---|---|
| Pages (from-to) | 8387-8390 |
| Number of pages | 4 |
| Journal | Angewandte Chemie - International Edition |
| Volume | 52 |
| Issue number | 32 |
| DOIs | |
| State | Published - 5 Aug 2013 |
| Externally published | Yes |
Keywords
- T790M mutants
- drug design
- inhibitors
- selectivity